DAVID GRANOVSKY

Archive for the ‘VICTORIES & SUCCESS STORIES’ Category

Engineered stem cells seek out and kill HIV infection in living organisms

In VICTORIES & SUCCESS STORIES on April 15, 2012 at 1:52 pm

“…stem cells can be genetically engineered into HIV-fighting cells…”

is there anything they can’t do???

http://cbssanfran.files.wordpress.com/2010/10/hiv_aids_generic.jpg?w=300

Engineered stem cells seek out and kill HIV infection in living organisms

Washington, Sun, 15 Apr 2012 ANI

Washington, Apr 15 (ANI): In a new study, scientists have expanded on previous research that had provided proof-of-principal that human stem cells can be genetically engineered into HIV-fighting cells.

This time, they have demonstrated that these cells can actually attack HIV-infected cells in a living organism.

The study by UCLA researchers demonstrate for the first time that engineering stem cells to form immune cells that target HIV is effective in suppressing the virus in living tissues in an animal model.

“We believe that this study lays the groundwork for the potential use of this type of an approach in combating HIV infection in infected individuals, in hopes of eradicating the virus from the body,” Scott G. Kitchen, lead investigator of the study, said.

In the previous research, the scientists took CD8 cytotoxic T lymphocytes – the “killer” T cells that help fight infection – from an HIV-infected individual and identified the molecule known as the T cell receptor, which guides the T cell in recognizing and killing HIV-infected cells.

However, these T cells, while able to destroy HIV-infected cells, do not exist in great enough quantities to clear the virus from the body. So the researchers cloned the receptor and used this to genetically engineer human blood stem cells.

http://www.differencebetween.co.in/wp-content/uploads/2011/05/Mouse.jpg

They then placed the engineered stem cells into human thymus tissue that had been implanted in mice, allowing them to study the reaction in a living organism.

The engineered stem cells developed into a large population of mature, multi-functional HIV-specific CD8 cells that could specifically target cells containing HIV proteins.

The researchers also discovered that HIV-specific T cell receptors have to be matched to an individual in much the same way an organ is matched to a transplant patient.

In this current study, the researchers similarly engineered human blood stem cells and found that they can form mature T cells that can attack HIV in tissues where the virus resides and replicates. They did so by using a surrogate model, the humanized mouse, in which HIV infection closely resembles the disease and its progression in humans.

In a series of tests on the mice’s peripheral blood, plasma and organs conducted two weeks and six weeks after introducing the engineered cells, the researchers found that the number of CD4 “helper” T cells – which become depleted as a result of HIV infection – increased, while levels of HIV in the blood decreased.

CD4 cells are white blood cells that are an important component of the immune system, helping to fight off infections. These results indicated that the engineered cells were capable of developing and migrating to the organs to fight infection there.

The researchers did note a potential weakness with the study: Human immune cells reconstituted at a lower level in the humanized mice than they would in humans, and as a result, the mice’s immune systems were mostly, though not completely, reconstructed.

Due to this, HIV may be slower to mutate in the mice than in human hosts. So the use of multiple, engineered T cell receptors may be one way to adjust for the higher potential for HIV mutation in humans.

“We believe that this is the first step in developing a more aggressive approach in correcting the defects in the human T cell responses that allow HIV to persist in infected people,” Kitchen added.

The study has been published in the journal PLoS Pathogens. (ANI)

Engineered stem cells seek out and kill HIV infection in living organisms.

Stem Cell Injections in Lou Gehrig’s Disease can be Given Safely

In VICTORIES & SUCCESS STORIES on April 11, 2012 at 12:16 am

WELCOME US MEDIA!!! WOO HOO!!

11 YEARS LATE TO THE PARTY:

A history of Amyotrophic Lateral Sclerosis (ALS) aka Lou Gehrig’s disease and stem cell treatments for humans going back to 2001.

http://repairstemcell.wordpress.com/amyotrophic-lateral-sclerosis-als/

http://upload.wikimedia.org/wikipedia/commons/thumb/2/2f/GehrigCU.jpg/200px-GehrigCU.jpg

Stem Cell Injections in Lou Gehrig’s Disease can be Given Safely, New Research Shows

ANN ARBOR, Mich., April 10, 2012 /PRNewswire-USNewswire/ – The first published results from an early-stage clinical trial show that spinal cord stem cells can be delivered safely into the spines of patients with the condition commonly known as Lou Gehrig‘s disease, opening the door for further research on this innovative approach.

In a paper published online ahead of print publication in the peer-reviewed journal Stem Cells, a team from the University of Michigan, Emory University and study sponsor NeuralStem, Inc. report the results from 12 patients who took part in a study being conducted at Emory.

All had amyotrophic lateral sclerosis, the inevitably fatal degenerative disease of the nervous system that many call Lou Gehrig‘s disease. None experienced any long-term complications related to either the surgical procedure or the implantation of stem cells, or showed signs of rejecting the cells. And in the months following the surgery to inject the cells, none showed evidence that their ALS progression was accelerating..

Stem Cell Injections in Lou Gehrig’s Disease can be Given Safely,… — ANN ARBOR, Mich., April 10, 2012 /PRNewswire-USNewswire/ –.


MEDICAL BOARD Gives Early OK to Adult Stem Cell Rules – Part 1

In VICTORIES & SUCCESS STORIES on April 8, 2012 at 8:55 pm

HUGE NEWS! WHAT THIS MEANS:

  • You can get stem cells in Texas.
  • They have to tell you they are not approved by the FDA.
  • They have be reviewed by an IRB – Institutional Review Board.

Medical Board Gives Early OK to Adult Stem Cell Rules

by Gerald Rich – February 10, 2012

After months of deliberation — and input from Gov. Rick Perry, among others — the Texas Medical Board on Friday gave preliminary approval to a set of rules on adult stem cells in Texas that are less stringent than those originally proposed.

With no opposition, the vote on a topic that has received much scrutiny and skepticism since last spring took only about five minutes.

“It’s been a delicate balance between our absolute goal to protect the public and at the same time [our] desire not to stifle what we feel will be a huge boon to medicine,” said Dr. George Willeford, a member of the board. “Perhaps we’ve been criticized by the media for taking a middle road, but [the middle road] was absolutely necessary.”

In the weeks leading up this meeting, members of many Texas academic institutions had written to the Board to express concern that the rules — “Standards for Use of Investigational Agents” — were too restrictive and created what they felt might be onerous regulations on any treatment that could be undergoing clinical trials.

Discussion of changing the Texas Administrative Code to include regulating these trials began last summer after Perry used adult stem cells to treat a recurring back injury. Perry learned of and advocated for the treatment after Dr. Stanley Jones — a Houston orthopedist, donor and personal friend of the governor — flew to Japan to receive the same treatment for his arthritis.

At the moment, extracting, growing and using adult stem cells is considered largely experimental and can cost anywhere from $10,000 to $50,000. However, those at the meeting expressed hope that this new treatment could eventually become affordable and accessible to more Texans.

Under the rules OK’d on Friday, patients will be informed that using adult stem cells, or any investigational agent, has not been approved by the FDA and that any clinical trials will be approved and overseen by an Institutional Review Board, or IRB.

The board and industry leaders hope this new rule will give them more data on the potential benefits of using adult stem cells. Currently, there is no substantial data to indicate that adult stem cells are beneficial for patients other than those undergoing bone marrow transplants — used for decades to treat leukemia and sickle cell anemia.

In late August, the board’s initial rule had included language requiring consent forms detailing the risks and benefits, and stating that any treatment offered needed to have a favorable risk/benefit ratio.

Now that the proposed change has been approved by the board, the rule will be printed in the Texas Register, where the public can view them and comment on them. Further drafts of the rule may be drawn up, with the final version put to vote for adoption during the April board meeting.

“Some language was removed and some was added,” said Mario Salinas, director of Texans for Stem Cell Research. ”Patients are going to be informed as to [the] pros and cons that will ensue from being in a clinical trial. Whatever language was deleted was made better with the new language that was added.”

Glenn McGee, president of strategic initiatives for Houston-based Celltex Therapeutics — which was founded by Jones and Perry donor David Eller, and is a Texas adult stem cell bank — was also in attendance Friday and happy with the proceedings.

“Texas decided, unlike anyone else in the country or anyone in the world, to take a position on how to think about stem cells and the practice of medicine,” McGee said. “I think Texas will become the source for articles about adult stem cell use in peer reviewed articles.”

Editor’s note: An earlier version of this story incorrectly reported that Celltex Therapeutics was the only Texas adult stem cell bank.

Read more: Medical Board Gives Early OK to Adult Stem Cell Rules — Health Reform and Texas | The Texas Tribune.

Related article: http://repairstemcell.wordpress.com/2012/04/08/medical-boards-proposed-stem-cell-policy-under-fire-part-2/
Background History: http://repairstemcell.wordpress.com/?s=perry

Ethan Zohn undergoes stem-cell transplant

In VICTORIES & SUCCESS STORIES on March 5, 2012 at 4:04 am

Ethan Zohn undergoes stem-cell transplant, thanks ‘Survivor’ girlfriend Jenna Morasca

His fighting spirit, family & friends keep him positive

By Joyce Chen / NEW YORK DAILY NEWS
Thursday, March 1, 2012, 4:39 PM

 	Ethan Zohn had a stem-cell transplant to treat his Hodgkin’s lymphoma.

Rob Loud/Getty Images

Ethan Zohn had a stem-cell transplant to treat his Hodgkin’s lymphoma.

Ethan Zohn is by all measures the definition of a true survivor.

The former “Survivor” winner underwent a stem-cell transplant Wednesday to treat his recurring case of Hodgkin’s lymphoma, and even under the serious circumstances, Zohn still had competition on his mind.

“Ethan asked the doctor what was the record time for getting out of here, so he wants to beat that,” Zohn’s longtime girlfriend Jenna Morasca told People.

“His doctor said there was no prize, and Ethan said, ‘Yes, there is. You’re going to tell the other patients that I made it out in three weeks.’”…

Read more: Ethan Zohn undergoes stem-cell transplant, thanks ‘Survivor’ girlfriend Jenna Morasca – NY Daily News.

Patient’s own stem cells help heal heart, early research shows – CNN.com

In CATCH UP!, VICTORIES & SUCCESS STORIES on February 14, 2012 at 3:27 am

7 long years.

It has taken 7 years for the US medical system to CATCH UP to the rest of the world.  This article, though pro-adult stem cell, uses the same tired, B.S. lines like:

“This is the first instance of therapeutic regeneration”

This article blatantly ignores the thousands of of studies, trials and patients successfully treated over the last 7 years.  Sadly, we won’t see stem cell treatments readily, commonly and commercially available in the US for a long time. 

Many people will offer comments on these developments…

The uninformed will say: “first time ever!”

The optimists will say: “better late than never”

The realists will say: “10 years before US patients will have access to these treatments”

The families of those who have died over the past 7 years will say: “if only the US woke up sooner”

……………………

Stem cell treatments are available NOW outside of the United States at some of the most modern and advanced hospitals and clinics in the world.  Maybe, just maybe, the families of those who WILL die from heart disease over the NEXT 10 years will say:

“NOW is the time to go where they have been treating heart disease with stem cells for over half a decade”

For info on CURRENTLY AVAILABLE stem cell treatments for heart disease:

http://bit.ly/stemcellsnow

For more info and the HISTORY of stem cells for heart disease :

http://repairstemcell.wordpress.com/heart-disease-treatment/

Patient's own stem cells help heal heart, early research shows

Patient’s own stem cells help heal heart, early research shows

A patient’s own heart cells can be used to regrow new heart tissue and help undo damage caused by a heart attack, according to early research published on Monday.

Scientists at Cedars-Sinai Medical Center in Los Angeles and Johns Hopkins University in Baltimore were able to treat 17 heart attack patients with cells grown from their own heart tissue and not only show the procedure was safe, but also that the cells can help reduce scarring and even cause new heart muscle to grow.

When a person suffers a heart attack, he or she is often left with huge areas of scarring in the heart. Scarred heart muscle doesn’t pump blood as well as it used to, putting stress on other parts of the heart to make up for the deficit. The damaged area also doesn’t conduct electric current as well, leading to an abnormal heart rhythm, which can cause more problems. Heart attack patients often go on to develop heart failure.

“This is the first instance of therapeutic regeneration,” says Dr. Eduardo Marbán, director of the Cedars-Sinai Heart Institute. He says while nature abounds with examples of spontaneous regeneration of limbs or tissues – like a salamander’s new tail or a human liver regrowing to full size if partially damaged – doctors have not been able to help patients regrow heart tissue. This could change in the future if larger clinical trials and longer patient outcomes confirm the results of this early research published Monday in the journal The Lancet.  Marbán and his colleagues first presented this research at an American Heart Association conference in November…

Patient’s own stem cells help heal heart, early research shows – – CNN.com Blogs.

Heart patient’s stem cells harnessed for healing – CBC News

In VICTORIES & SUCCESS STORIES on January 27, 2012 at 1:26 pm
Not bad. They are only a half decade behind the times. – DG

Heart patient’s stem cells harnessed for healing

Some heart bypass patients are receiving cardiac stem cell transplants to try to repair damage.

This week, a 67-year-old James Culross from Toronto will be discharged from Toronto General Hospital after having 2.83 million stem cells injected into seven sites where his heart had been damaged by a heart attack in November.

When someone suffers a heart attack, part of the heart muscle dies and is replaced by a scar. In larger heart attacks, the patient can develop heart failure — a weakening of the heart that leaves the patient short of breath, said cardiac surgeon Dr. Terrence Yau of Toronto’s University Health Network.

Heart patient James Culross was the donor and recipient of his own stem cells. Heart patient James Culross was the donor and recipient of his own stem cells. (CBC)

Yau and his colleagues at Toronto General’s Peter Munk Cardiac Centre and Maisonneuve-Rosemont Hospital in Montreal are involved in a clinical trial testing the safety, effectiveness and feasibility of injecting stem cells into the hearts of people having bypass surgery.

“This kind of therapy can improve the function and blood flow of hearts that have been injured by heart attacks most commonly and potentially by other means as well,” said Yau.

About 50,000 Canadians are diagnosed with advanced heart failure each year. On average, men live only 18 months and women three years after diagnosis.

While angioplasty, bypass surgery and stents can prevent new heart attacks, they don’t reverse exisiting damage. A new heart is the only known treatment for that, but transplants are invasive and expensive, and there is a lack of available donor organs.

That’s where the stem cells could come in.

Stem cells taken from marrow

In Culross’s case, the stem cells were taken from the bone marrow in the hip and lower back in the operating suite. After four to six hours, the stem cells were isolated, the bypass grafts done and the stem cells injected back into the damaged areas of his heart.

“I thought it was great,” Culross said of the procedure. “It’s your stem cells, nobody else’s.”

Culross is now working on improving his strength and walking more in the hopes of returning to his auto body repair job.

Since 2010, eight patients have also had the experimental procedure in Montreal.

The Montreal and Toronto teams plan to combine their findings once each has results on 20 patients.

No one knows yet whether the stem cell treatment will improve survival or quality of life by healing the heart.

Investigators worldwide are testing whether giving stem cells after a heart attack works better than existing therapies.

Heart patient’s stem cells harnessed for healing – Health – CBC News.

Men Replaced: Killing Spiders Not Enough

In VICTORIES & SUCCESS STORIES on January 24, 2012 at 4:20 am
Researchers to build artificial testicles for infertile men
San Francisco – Researchers in California are working to build an artificial testicle, a human “sperm-making biological machine,” that can produce human sperm and allow otherwise infertile men to make babies.
According to My Health News Daily, Dr. Paul Turek, director of the Turek Clinic, a men’s health medical practice in San Francisco, says that recent advances show that the idea of treating infertility in male animals by producing sperm using stem cells is feasible. While this has been done successfully in mice, it has not been done in humans.
Turek recently announced on his Turek on Men’s Health site that he has received a government grant to develop a human “sperm-making biological machine.” According to My Health News Daily, Turek and his colleague, Dr. Constance John, chief executive of MandalMed Inc., a biotech company in San Francisco, received a small research grant from the National Institute of Environmental Health Sciences.
Turek says the new “machine” will not be designed to resemble a testicle like non-sperm-producing prosthesis that are saline-filled implant for men who don’t have testicles. Rather, the sperm producing machine will come as a cylindrical bag a few inches in length and will look “like a transparent, over-sized Tootsie Roll.”
Turek on Men’s Health explains: “To be clear, this grant is not about creating a testicular implant for a man who is missing a real one. We did that a decade or so ago. This award is to develop a sperm making biological machine…We now have a couple of years to create human artificial sperm in a dish, or more formally, a ‘bioreactor,’ a fancy dish to be sure.” …

Read more: http://www.digitaljournal.com/article/318149#ixzz1kHKdE2hL

WHAT IF GERTRUDE STEIN AND MR. ED HAD A STEM CELL BABY…

In VICTORIES & SUCCESS STORIES on January 23, 2012 at 4:01 am

Some articles are not only fascinating but they lend themselves so easily to have a little bit of fun with.  With apologies to both Gertrude Stein and Mr. Ed (and a richly deserved apology to the good Dr. Goodrich):

WHAT IF GERTRUDE STEIN AND MR. ED

LITERALLY HAD A STEM CELL BABY…

The following study researched the effectiveness of bone marrow stem cells taken from 2 different sites on horses – the hip bone (iliac crest) and the sternum.

In the end, there was very little difference between the results of stem cells taken from the two sites.  This information has extremely significant therapeutic relevance as doctors can now focus on other criteria for site selection; ease of extraction, quantity of  cells, proportion of cell types, etc.  Further, this study reinforces the idioms:

“A ROSE IS A ROSE IS A ROSE”

“A STEM CELL IS A STEM CELL IS A STEM CELL”

“A HORSE IS A HORSE, OF COURSE, OF COURSE”

“A HORSE STEM CELL IS A HORSE STEM CELL, OF COURSE, OF COURSE”

Apologies to Will Shakespeare for being odd man out at the dance.  Now to worry; you are gone but not forgotten.

“A stem cell by any other derivation site would smell just as sweet.”

(Four more equine stem cell articles below)

………………

Bone Marrow-Derived Stem Cell Sources Compared (AAEP 2011)

Stem cell source site has been debated among researchers in recent years as stem cells have been gaining popularity in equine medicine. A research group at Colorado State University recently compared the use of bone marrow-derived mesenchymal stem cells from two sites on the horse’s body to determine which might be most effective for treating specific soft tissue injuries. Laurie Goodrich, DVM, PhD, Dipl. ACVS, presented results at the 2011 American Association of Equine Practitioners Convention, held Nov. 18-22 in San Antonio, Texas.

According to Goodrich, stem cells are particularly useful for treating tissues such as joints and tendons-these tissues lack regenerative capability due to a deficiency in local stem cell response. Stem cells have been derived from adipose tissue (fat) and bone-marrow. However, for tendon healing, bone marrow-derived cells yield better matrix and collagen production, she noted.

The research team compared bone marrow-derived mesenchymal stem cells (BM-MSCs) from the two most common extraction sites in the horse: the sternum (breastbone) and the ilium (hip). For BM-MSC therapy to be effective, Goodrich said two aspects are crucial: using large numbers of cells (roughly 5-10 million cells/centimeter in tendon and 5-10 million cells/joint) and implanting the cells early during the critical period between the inflammatory and fibroblastic phases of healing.

Goodrich discussed previously noted advantages and disadvantages for each site:

For the sternum:

  • Advantages
    • The bone marrow aspirate flows better into the syringe;
    • The amount of aspirate is not influenced by age of the horse; and
    • Cells are easier to collect.
  • Disadvantages:
    • The site is close to vital structures (heart, lungs); and
    • The collector must crouch under the horse.

For the ilium:

  • Advantages
    • Practitioner doesn’t have to crouch while obtaining cells; and
    • There’s no risk of jabbing the heart or lungs.
  • Disadvantages
    • It’s more difficult to get adequate cell volume;
    • The sample size is age-dependent; and
    • Ilial samples often result in unsuccessful culture.

Explore the power of the human-horse connection as you travel the emotional journey that veterinarians at Rood and Riddle Equine Hospital and owners embark on when a beloved horse becomes ill in Equine ER

Researchers and clinicians had also noticed that the cells from sternal samples appeared different from those in ilial bone marrow samples.

Goodrich’s study sought to provide clinicians with better information to guide selection site and on whether the health of the MSCs varied between separate samples or (fractions) of bone marrow drawn from a site at one time. Goodrich and her co-authors examined two sequential 5 mL samples from both sternal and ilial bone marrow aspirates of seven horses (they “plated” cells from the sample/grew them in culture, referred to as a “passage”). They found that:

  • The first fractions of both samples yielded the highest cell counts;
  • The cells of the first fraction were no healthier than those of the second;
  • The health of the sternal and ilial samples was the same;
  • By the second and third culture passages, cell morphologies were similar between the two sites; and
  • Aspirates greater than 5-10 mL produced insignificant increases to the nucleated cell count.
  • Goodrich noted the following limitations to the study:
  • A relatively small number of horses was used;
  • There was some variability in age and gender of the horses; and
  • They didn’t calculate the cell-doubling times, although the measurement of cell numbers at each passage was more relevant.

Goodrich’s team concluded that bone marrow aspiration site should depend on clinician preference, since the cells of one site do not appear to be superior to the other.

via The Horse | Bone Marrow-Derived Stem Cell Sources Compared (AAEP 2011).

OTHER EQUINE STEM CELL ARTICLES:

Lions and puppys and horseys, oh my! « The Stem Cell Blog

repairstemcell.wordpress.com/…/lions-and-puppys-and-horseys-oh-m…

Mar 7, 2009 – http://repairstemcell.wordpress.com/2009/02/27/horse-racing-horse-racing-samantha-miss-has-stem-cell-treatment/

ANIMALS + STEM CELLS « The Stem Cell Blog

repairstemcell.wordpress.com/animals-stem-cells/

http://repairstemcell.wordpress.com/2009/02/27/equine-clinic-is-full-service-care-for-hoofed-friends-thecaliforniancom-the-salinas-californian/

GERON GIVES UP on EMBRYONIC STEM CELLS! « The Stem Cell …

repairstemcell.wordpress.com/…/geron-gives-up-on-embryonic-stem-…

Nov 14, 2011 – If Embryonic treatments were a horse race, Geron would be the strongest ….. repairstemcell.wordpress.com/2009/02/18/jewish-law-articles-the-

KCBS – Stem Cell Research on Horses Holds Promise for Human …

repairstemcell.wordpress.com/…/kcbs-stem-cell-research-on-horses-h…

May 20, 2009 – http://repairstemcell.wordpress.com/2009/02/27/equine-clinic-is-full-service-care-for-hoofed-friends-thecaliforniancom-the-salinas-californian/

CellNEWS: Scientists Learn How Stem Cell Implants Help Heal Traumatic Brain Injury

In VICTORIES & SUCCESS STORIES on January 22, 2012 at 9:20 am

“In this study, we found that our stem cell transplantation both prevents further axonal injury and promotes axonal regrowth, through a number of previously unknown molecular mechanisms.”

http://trialx.com/curetalk/wp-content/blogs.dir/7/files/2011/06/Tramautic_Brain_Injury.jpg

Scientists Learn How Stem Cell Implants Help Heal Traumatic Brain Injury  
Friday, 13 January 2012

For years, researchers seeking new therapies for traumatic brain injury have been tantalized by the results of animal experiments with stem cells. In numerous studies, stem cell implantation has substantially improved brain function in experimental animals with brain trauma. But just how these improvements occur has remained a mystery.

Now, an important part of this puzzle has been pieced together by researchers at the University of Texas Medical Branch at Galveston. In experiments with both laboratory rats and an apparatus that enabled them to simulate the impact of trauma on human neurons, they identified key molecular mechanisms by which implanted human neural stem cells — stem cells that are in the process of developing into neurons but have not yet taken their final form — aid recovery from traumatic axonal injury.
A significant component of traumatic brain injury, traumatic axonal injury involves damage to axons and dendrites, the filaments that extend out from the bodies of the neurons. The damage continues after the initial trauma, since the axons and dendrites respond to injury by withdrawing back to the bodies of the neurons.
“Axons and dendrites are the basis of neuron-to-neuron communication, and when they are lost, neuron function is lost,” said UTMB professor Ping Wu, lead author of a paper on the research appearing in the Journal of Neurotrauma.

“In this study, we found that our stem cell transplantation both prevents further axonal injury and promotes axonal regrowth, through a number of previously unknown molecular mechanisms.”

 

Read more: CellNEWS: Scientists Learn How Stem Cell Implants Help Heal Traumatic Brain Injury.

HEARTS and KNEES – Patient, heal thyself | sciencebuz

In VICTORIES & SUCCESS STORIES on January 21, 2012 at 9:20 am

“The first study…uses stem cell therapy to repair heart tissue damaged by coronary heart disease. Of the 16 patients injected with autologous CSCs, 14 showed an increase in Left Ventricular Ejection Fraction (LVEF)…In seven of the patients, infarct (dead tissue) size decreased by 24 % at the end of 4 months, and a further 6 % at the end of a year. Both these results indicate CSCs had a positive impact on heart tissue regeneration.

The second study…focuses on using autologous stem cell therapy for repair of torn meniscal tissue…The “Cell Bandage” from Azellon will use patients own, expanded stem cells, harvested from the bone marrow…will grow into new menisci-type cells and heal the tear. The results of in vitro trials have so far been very promising. Phase I clinical trials are set to begin May 2012.”

http://www.designmom.com/wp-content/uploads/2011/02/5417124292_6a49ef3983.jpg

Two reports in the press this week focus on the use of autologous (patient’s own) stem cells for repair of damaged tissue.

The first study, led by Professor Roberto Bolli, of the University of Louisville, reports on early findings of a phase I clinical trial, which uses stem cell therapy to repair heart tissue damaged by coronary heart disease. Cardiac tissue, harvested from the patient during surgery, was used to  isolate autologous cardiac stem cells (CSCs). CSCs were grown in the laboratory till their numbers reached around 2 million cells. At this stage the cells were re-injected back at the site of tissue damage.

Of the 16 patients injected with autologous CSCs, 14 showed an increase in Left Ventricular Ejection Fraction (LVEF) – the amount of blood a left ventricle pumps through the aorta during each contraction of the heart, 4 months after infusion. In seven of the patients, infarct (dead tissue) size decreased by 24 % at the end of 4 months, and a further 6 % at the end of a year. Both these results indicate CSCs had a positive impact on heart tissue regeneration.

The second study, led by Professor Anthony Hollander, of Azellon Ltd, a University of Bristol spin-out company, focuses on using autologous stem cell therapy for repair of torn meniscal tissue. The menisci are found at the knee joints, and they act as shock absorbers for the knee. This tissue is often damaged as a result of sport-related injury, especially contact sports such as football or rugby.

Current treatment options include knee arthroscopy surgery, which involves removing part or whole of the damaged meniscal tissue. This reduces the shock-absorbing properties at the knee joint and leaves the patient vulnerable to early-onset osteoarthritis, eventually followed by total knee replacement.

The “Cell Bandage” from Azellon will use patients own, expanded stem cells, harvested from the bone marrow. These cells are seeded onto a special biocompatible membrane, which will be inserted at the site of damage using a simple surgical procedure.  Given the right conditions, the hope is that stem cells will grow into new menisci-type cells and heal the tear. The results of in vitro trials have so far been very promising. Phase I clinical trials are set to begin May 2012.

Patient, heal thyself | sciencebuz.

Follow

Get every new post delivered to your Inbox.

Join 819 other followers